Article: Combination of Antistaphylococcal β-Lactam With Standard Therapy Compared to Standard Therapy Alone for the Treatment of Methicillin-Resistant
Open forum infectious diseases
2024 Volume 11, Issue 5, Page(s) ofae181
Abstract: Background: Desirability of outcome ranking (DOOR) is an emerging approach to clinical trial outcome measurement using an ordinal scale to incorporate efficacy and safety endpoints.: Methods: We applied a previously validated DOOR endpoint to a ... ...
Abstract | Background: Desirability of outcome ranking (DOOR) is an emerging approach to clinical trial outcome measurement using an ordinal scale to incorporate efficacy and safety endpoints. Methods: We applied a previously validated DOOR endpoint to a cohort of CAMERA2 trial participants with methicillin-resistant Results: Participants assigned combination therapy had a 54.5% (95% confidence interval [CI], 48.9%-60.1%; Conclusions: When considering both efficacy and safety, treatment of MRSAB with a combination of standard therapy and a β-lactam likely results in a worse clinical outcome than standard therapy. However, a small benefit of combination therapy cannot be excluded. Most likely the toxicity of combination therapy outweighed any benefit from faster clearance of bacteremia. |
---|---|
Language | English |
Publishing date | 2024-04-25 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 2757767-3 |
ISSN | 2328-8957 |
ISSN | 2328-8957 |
DOI | 10.1093/ofid/ofae181 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.